共 50 条
- [1] Short-term use of rofecoxib increases the risk for adverse cardiovascular events [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (11): : 621 - 621
- [3] Short-Term Change in eGFR and Risk of Cardiovascular Events [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (05):
- [9] Methylphenidate and Short-Term Cardiovascular Risk [J]. JAMA NETWORK OPEN, 2024, 7 (03) : E241349